ERBB2 and breast cancer: In addition, enhanced expression profile of the pentose phosphate pathway-related enzymes such is 6PGDH and TKT is also evident in breast cancer [59, 60], especially in HER-2 and triple negative types [61], which is again associated with poor clinical prognosis [62–64].